Each reaction contains 250 nM TrxR1, 300 M Nicotinamide adenine dinucleotide phosphate (NADPH) (N5130-25 MG, Sigma) and 5 mM DTNB in buffer containing 100 mM potassium phosphate, 1 mM Ethylenediaminetetraacetic acid (EDTA) (E4378-25G, Sigma), pH 7.0
Who should wait or get clearance People with kidney disease, congestive heart failure, uncontrolled hypertension, severe liver disease, pregnancy, or medications that prolong the QT interval should speak with their physician first
[DOI] [PubMed] [Google Scholar] 102.Figlioli G, Piovani D, Peppas S, et al
The argument that arginate salt formulation constitutes a distinct compound outside the FDA's BPC-157 Category 2 ruling has not been validated by any FDA guidance